A novel atrial flow regulator in heart failure patients
This video is supported by Occlutech
Summary
Martin W. Bergmann presents the 3-month results of the PRELIEVE Trial, a pilot study to assess the safety and efficacy of a novel atrial flow regulator that aims to reduce elevated left atrial pressure in patients with heart failure. Can the device improve symptoms of dyspnoea in this patient population? Might it lead to a new approach to heart failure treatment? Watch to find out more…
This interview supported by Occlutech was filmed at EuroPCR 2019: see more videos here…